zum Inhalt wechseln
Long-Term Consequences of Drugs on the Paediatric Cardiovascular System
SchließenTitelvorschau
Prüfung…

Long-Term Consequences of Drugs on the Paediatric Cardiovascular System

Verfasser/in: Elizabeth HausnerMonica FiszmanJoseph HanigPatricia HarlowGwen ZornbergAlle Autoren
Verlag: Adis International Limited
Ausgabe/Format Artikel Artikel : Englisch
Veröffentichung:Drug Safety, 31, no. 12 (2008): 1083-1096
Datenbank:ArticleFirst
Andere Datenbanken: WorldCatWorldCatBritish Library Serials
Bewertung:

(noch nicht bewertet) 0 mit Rezensionen - Verfassen Sie als Erste eine Rezension.

Ähnliche Titel

 

&AllPage.SpinnerRetrieving;

Exemplar ausleihen

&AllPage.SpinnerRetrieving; Suche nach Bibliotheken, die diesen Titel besitzen ...

Details

Dokumenttyp: Aufsatz
Alle Autoren: Elizabeth Hausner; Monica Fiszman; Joseph Hanig; Patricia Harlow; Gwen Zornberg; Solomon Sobel
ISSN:0114-5916
Sprachhinweis: English
Identifikator: 365863444
Auszeichnungen:

Rezensionen

Nutzer-Rezensionen
Suche nach GoodReads-Rezensionen
Suche nach DOGObooks-Rezensionen…

Tags

Alle Nutzer-Tags (1)

Anzeige der beliebtesten Schlagwörter als: Schlagwortliste | Tag Cloud

  • good  (von 1 Person)

Ähnliche Titel

Nutzerlisten mit diesen Titeln (1)

Anfrage bestätigen

Sie haben diesen Titel bereits angefordert. Wenn Sie trotzdem fortfahren möchten, klicken Sie auf OK.

Verlinkung


Primary Entity

<http://www.worldcat.org/oclc/365863444> # Long-Term Consequences of Drugs on the Paediatric Cardiovascular System
    a schema:Article, schema:CreativeWork ;
    library:oclcnum "365863444" ;
    rdfs:comment "949 $l Review Article" ;
    schema:about <http://experiment.worldcat.org/entity/work/data/159255745#Thing/heart> ; # Heart
    schema:about <http://experiment.worldcat.org/entity/work/data/159255745#Thing/cardiovascular_disorders> ; # Cardiovascular disorders
    schema:about <http://experiment.worldcat.org/entity/work/data/159255745#Thing/children> ; # Children
    schema:about <http://experiment.worldcat.org/entity/work/data/159255745#Thing/adverse_drug_reactions> ; # Adverse drug reactions
    schema:contributor <http://experiment.worldcat.org/entity/work/data/159255745#Person/sobel_solomon> ; # Solomon Sobel
    schema:contributor <http://experiment.worldcat.org/entity/work/data/159255745#Person/fiszman_monica> ; # Monica Fiszman
    schema:contributor <http://experiment.worldcat.org/entity/work/data/159255745#Person/harlow_patricia> ; # Patricia Harlow
    schema:contributor <http://experiment.worldcat.org/entity/work/data/159255745#Person/zornberg_gwen> ; # Gwen Zornberg
    schema:contributor <http://experiment.worldcat.org/entity/work/data/159255745#Person/hanig_joseph> ; # Joseph Hanig
    schema:creator <http://experiment.worldcat.org/entity/work/data/159255745#Person/hausner_elizabeth> ; # Elizabeth Hausner
    schema:datePublished "2008-12-11" ;
    schema:description "Many pharmacological and toxicological actions of drugs in children cannot be fully predicted from adult clinical experience or from standard non-clinical toxicology studies. Numerous drugs have direct or indirect pharmacological effects on the heart and are prescribed for children of all ages. Toxicity or secondary effects may be immediate or delayed for years after drug exposure has ceased. Originally, the aim of this review was to compile information on the effect of specific drugs on the post-natal development of the cardiovascular system and to examine long-term follow-up of the use of cardio-active drugs in children. The limited database of published information caused the original question to evolve into an examination of the medical literature for three areas of information: (i) whether vulnerable developmental windows have been identified that reflect the substantial functional development that the cardiovascular system undergoes after birth; (ii) what is known about pharmacological perturbation of development; and (iii) what the likelihood is of drug exposure during childhood. We examined different scenarios for exposure including random, isolated exposure, conditions historically associated with adults, primary or secondary cardiac disease, psychiatric and neurological conditions, asthma, cancer and HIV. Except for random, isolated drug exposures, each category of possible exposure contained numerous drugs known to have either primary or secondary effects on the cardiovascular system or to influence factors associated with atherosclerosis. It is likely that a significant number of children will be prescribed drugs having either direct or indirect effects upon the immature cardiovascular system. A confounding factor is the simultaneous use of over-the-counter medications and herbal or nutraceutical preparations that a patient, parent or guardian does not mention to a prescribing physician. Metabolism is also important in assessing drug effects in children. Differences in body water : body fat ratio, age-related gastrointestinal absorption, distribution, excretion, renal function and drug metabolizing capabilities make it possible for children to have a different metabolite profile for a drug compared with adults. There is little examination of drug effects on the interdependent processes of cardiac maturation and less examination of metabolite effects. It is difficult to identify delayed toxicities in children as these adverse events may take years to manifest with many patients lost to follow-up. Clearly this is an area of study where intermediate endpoints and surrogate markers would be of great benefit. Pharmacogenomics may be useful in providing markers of increased risk or susceptibility. A perspective must be kept in balancing the possibility of a problem with the very real benefits that many children experience from the use of these pharmaceuticals." ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/159255745> ;
    schema:inLanguage "en" ;
    schema:isPartOf <http://worldcat.org/issn/0114-5916#31_12> ;
    schema:name "Long-Term Consequences of Drugs on the Paediatric Cardiovascular System" ;
    schema:pageStart "1083" ;
    schema:productID "365863444" ;
    schema:publication <http://www.worldcat.org/title/-/oclc/#PublicationEvent/adis_international_limited> ;
    schema:publisher <http://experiment.worldcat.org/entity/work/data/159255745#Agent/adis_international_limited> ; # Adis International Limited
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/365863444> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/159255745#Agent/adis_international_limited> # Adis International Limited
    a bgn:Agent ;
    schema:name "Adis International Limited" ;
    .

<http://experiment.worldcat.org/entity/work/data/159255745#Person/harlow_patricia> # Patricia Harlow
    a schema:Person ;
    schema:name "Patricia Harlow" ;
    .

<http://experiment.worldcat.org/entity/work/data/159255745#Person/hausner_elizabeth> # Elizabeth Hausner
    a schema:Person ;
    schema:name "Elizabeth Hausner" ;
    .

<http://experiment.worldcat.org/entity/work/data/159255745#Thing/adverse_drug_reactions> # Adverse drug reactions
    a schema:Thing ;
    schema:name "Adverse drug reactions" ;
    .

<http://experiment.worldcat.org/entity/work/data/159255745#Thing/cardiovascular_disorders> # Cardiovascular disorders
    a schema:Thing ;
    schema:name "Cardiovascular disorders" ;
    .

<http://worldcat.org/issn/0114-5916>
    a schema:Periodical ;
    rdfs:label "Drug Safety" ;
    schema:issn "0114-5916" ;
    .


Content-negotiable representations

Fenster schließen

Bitte in WorldCat einloggen 

Sie haben kein Konto? Sie können sehr einfach ein kostenloses Konto anlegen,.